Codon-optimized papilloma virus sequences

Details for Australian Patent Application No. 2001275695 (hide)

Owner Glaxo Group Limited

Inventors Ring, Christopher J.; Gough, Gerald W.; Ertl, Peter F.

Agent Davies Collison Cave

Pub. Number AU-B-2001275695

PCT Pub. Number WO02/08435

Priority 0017990 21.07.00 GB; 0025802 20.10.00 GB

Filing date 20 July 2001

Wipo publication date 5 February 2002

Acceptance publication date 27 January 2005

International Classifications

C12N 015/86 Mutation or genetic engineering - Viral vectors

A61K 039/12 Medicinal preparations containing antigens or antibodies - Viral antigens

C07K 014/025 Peptides having more than 20 amino acids

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

27 January 2005 Application Accepted

  Published as AU-B-2001275695

26 May 2005 Standard Patent Sealed

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001275696

2001275694